SANTA MONICA, Calif.--()--The Prostate Cancer Foundation (PCF) will launch PCF China, an in-country research initiative, with the First Annual PCF China Scientific Symposium. It will be held Friday, March 9 at the Peking University Wu Jieping Urology Center. The program is being held in association with the China Urological Association and will feature presentations from both Chinese and American prostate cancer experts. Based in the U.S., PCF has committed to identifying, funding and promoting innovative research projects within China—with an ultimate goal of ending death and suffering from prostate cancer.
1st Annual PCF China Scientific Symposium
Friday, 09 March, 2012 – 09:00-15:00
Peking University Wu Jieping Urology Center
No. 9 Yin Yuan Zhuang Road
Shi Jing Shan District, Beijing 100144
PCF China Young Investigator Awards Dinner & Ceremony
Friday, 09 March, 2012 – 18:00-21:00
Space is limited. Prostate cancer researchers and members of the press who are interested in attending these events can register at: http://pcf.kintera.org/chinasymposium.
The PCF China Young Investigator Awards provide a three-year grant of $37,500 per year. In total, the Prostate Cancer Foundation has more than 90 Young Investigator Awards, spanning seven countries and 44 research institutes—a $20.25 U.S. million investment.
About the Prostate Cancer Foundation in China
The Prostate Cancer Foundation China (PCF China), an initiative of the Prostate Cancer Foundation (PCF), identifies, funds, and promotes innovative research projects within China to end death and suffering from prostate cancer. Working with established Chinese institutions such as the Chinese Urological Association, PCF China stimulates and builds the prostate cancer research enterprise in China as well as encourages sustainable collaborations through the PCF World-Wide Knowledge Exchange. PCF China commenced in August 2011.
About the Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization funding and accelerating research. Founded in 1993, PCF has raised more than $475 million and provided funding to over 1,600 research projects at nearly 200 institutions in 15 countries around the world. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds supporting transformational cancer research. Our efforts have helped produce a 20-fold increase in U.S. government funding for prostate cancer. More information about PCF can be found at www.pcf.org.